摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl 2-{4,7-bis[2-(tert-butoxy)-2-oxoethyl]-1,4,7-triazanonan-1-yl}-4-(4-nitrophenyl)butanoate | 1598386-19-6

中文名称
——
中文别名
——
英文名称
tert-butyl 2-{4,7-bis[2-(tert-butoxy)-2-oxoethyl]-1,4,7-triazanonan-1-yl}-4-(4-nitrophenyl)butanoate
英文别名
——
tert-butyl 2-{4,7-bis[2-(tert-butoxy)-2-oxoethyl]-1,4,7-triazanonan-1-yl}-4-(4-nitrophenyl)butanoate化学式
CAS
1598386-19-6
化学式
C29H46N4O8
mdl
——
分子量
578.706
InChiKey
WHWPTDYSGYNYHF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.67
  • 重原子数:
    41.0
  • 可旋转键数:
    10.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    131.76
  • 氢给体数:
    0.0
  • 氢受体数:
    11.0

反应信息

  • 作为反应物:
    描述:
    tert-butyl 2-{4,7-bis[2-(tert-butoxy)-2-oxoethyl]-1,4,7-triazanonan-1-yl}-4-(4-nitrophenyl)butanoate盐酸 作用下, 以 为溶剂, 反应 3.0h, 以89%的产率得到2-[4,7-bis(carboxymethyl)-1,4,7-triazanonan-1-yl]-4-(4-nitrophenyl)butanoic acid
    参考文献:
    名称:
    Novel hexadentate and pentadentate chelators for 64Cu-based targeted PET imaging
    摘要:
    A series of new hexadentate and pentadentate chelators were designed and synthesized as chelators of Cu-64. The new pentadentate and hexadentate chelators contain different types of donor groups and are expected to form neutral complexes with Cu(II). The new chelators were evaluated for complex kinetics and stability with Cu-64. The new chelators instantly bound to Cu-64 with high labeling efficiency and maximum specific activity. All Cu-64-radiolabeled complexes in human serum remained intact for 2 days. The Cu-64-radiolabeled complexes were further challenged by EDTA in a 100-fold molar excess. Among the Cu-64-radiolabeled complexes evaluated, Cu-64-complex of the new chelator E was well tolerated with a minimal transfer of Cu-64 to EDTA. Cu-64-radiolabeled complex of the new chelator E was further evaluated for biodistribution studies using mice and displayed rapid blood clearance and low organ uptake. Cu-64-chelator E produced a favorable in vitro and in vivo complex stability profiles comparable to Cu-64 complex of the known hexadentate NOTA chelator. The in vitro and in vivo data highlight strong potential of the new chelator E for targeted PET imaging application. (C) 2014 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmc.2014.02.041
  • 作为产物:
    描述:
    d,l-2-bromo-4-(4-nitrophenyl)butanoic acid methyl ester1,4,7-三氮杂环壬烷-1,4-二乙酸二叔丁酯N,N-二异丙基乙胺 作用下, 以 乙腈 为溶剂, 反应 168.0h, 以51%的产率得到tert-butyl 2-{4,7-bis[2-(tert-butoxy)-2-oxoethyl]-1,4,7-triazanonan-1-yl}-4-(4-nitrophenyl)butanoate
    参考文献:
    名称:
    Novel hexadentate and pentadentate chelators for 64Cu-based targeted PET imaging
    摘要:
    A series of new hexadentate and pentadentate chelators were designed and synthesized as chelators of Cu-64. The new pentadentate and hexadentate chelators contain different types of donor groups and are expected to form neutral complexes with Cu(II). The new chelators were evaluated for complex kinetics and stability with Cu-64. The new chelators instantly bound to Cu-64 with high labeling efficiency and maximum specific activity. All Cu-64-radiolabeled complexes in human serum remained intact for 2 days. The Cu-64-radiolabeled complexes were further challenged by EDTA in a 100-fold molar excess. Among the Cu-64-radiolabeled complexes evaluated, Cu-64-complex of the new chelator E was well tolerated with a minimal transfer of Cu-64 to EDTA. Cu-64-radiolabeled complex of the new chelator E was further evaluated for biodistribution studies using mice and displayed rapid blood clearance and low organ uptake. Cu-64-chelator E produced a favorable in vitro and in vivo complex stability profiles comparable to Cu-64 complex of the known hexadentate NOTA chelator. The in vitro and in vivo data highlight strong potential of the new chelator E for targeted PET imaging application. (C) 2014 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmc.2014.02.041
点击查看最新优质反应信息

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸